COVIDE 19 – CONVALESCENT PLASMA AS A OPTIONAL TREATMENT
Komal Satav*, Trusha Shangrapawar and Dr. Ashok Bhosale
Abstract
The 2019 novel coronavirus (2019-nCoV) or the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new public
health crises threatening the earth with the emergence. The virus
originated in bats and was transmitted to humans through yet unknown
intermediary animals in Wuhan, China in December 2019. No drugs
are currently approved for Coronavirus Disease-2019 (COVID-19),
although some are tried. This review focuses on convalescent plasma
treatment to treat COVID -19. Plasma provided by COVID-19
convalescent patients may provide therapeutic relief because the
number COVID-19 cases escalate steeply world-wide. The respiratory
diseases including SARS-CoV related pneumonia suggest that convalescent plasma can
reduce mortality.
Keywords: Convalescent plasma, COVID-19, Antibody.
[Full Text Article]